Company | GLAXO | Symbol |
Company Name | Glaxosmithkline (Pak) Ltd. | Company Name |
Sector | Pharma and Bio Tech | Sector |
Avg EPS | Rs 7.68 | Average of past year end EPS's |
Sector Average | Rs 19.88 | Sector average of the above |
Avg EPS FV | Rs 57.16 | Fair Value (DCF) based on average of past year-end EPS's |
EPS | Rs 4.42 | Last four quarters EPS |
Sector Average | Rs 26.29 | Sector average of the above |
EPS FV | Rs 32.89 | Fair Value (DCF) based on last four quarters EPS |
Current Price | Rs 133.28 | Last closing stock price |
Updated | December 2013 | Data Month/Year |
Div | Rs 4.00 | Total dividend paid during last four quarters |
Sector Average | Rs 13.17 | Sector average of the above |
Div FV | Rs 29.76 | Fair value (DD) based on total dividend paid during last four quarters |
Avg Div | Rs 5.70 | Average of yearly dividends paid (including currently paid ones) |
Sector Average | Rs 10.60 | Sector average of the above |
Avg Div FV | Rs 42.41 | Fair value (DD) based on Average of yearly dividends paid (including current) |
Avg | Rs 30.12 | Fair value (averaged of other fair values) |
Upside | -77.40% | Upside potential (in percentage) based on the above Average. |
Div Yield | 3.00% | Dividend yield |
Sector Average | 2.64% | Sector average of the above |
Book Value | Rs 39.62 | Book Value |
Sector Average | Rs 193.62 | Sector average of the above |
FV FCF/S | Rs 18.94 | Fair Value based on free cash flow per share |
Outstanding Shares | 289,515,706 | Number of Outstanding Shares |
Current Assets | Rs 9,404.00 | Currency in Millions of Pakistan Rupees |
Total Liabilities | Rs 4,772.00 | Currency in Millions of Pakistan Rupees |
NCAV/S | Rs 16.00 | Net Current Asset Value / Share |
NNWC/S | Rs 4.20 | Net Net Working Capital / Share |
Total Assets | Rs 16,243.00 | Currency in Millions of Pakistan Rupees |
Quarter | December 2012 | Financial Report Quarter |
CfO | Rs 2,235.00 | Cash from Operations (Millions of Rs) |
FCF/S | Rs 2.55 | Free Cash Flow per Share |
FCF/S Sector Avg | -3.78 | Sector Average FCF/S |
P/FCF | 52.36 | Price over free cash flow |
P/FCF Sector Avg | 28.33 | Sector Average P/FCF |
P/E | 30.15 | Price over earnings ratio |
P/E Sector Avg | -1.35 | Sector Average P/E |
P/B | 3.36 | Price over book value ratio |
P/B Sector Avg | 3.31 | Sector Average P/B |
PR | 90.50 | Payout Ratio (in %) |
PR Sector Avg | 3.21 | Sector average Payout Ratio (in %) |
D/E Ratio | 41.60 | Debt / Equity ratio (%) |
Sector D/E Ratio | 84.47 | Sector Debt / Equity ratio (%) |
Price Performance | ||
Last Trade Date | 09/12/2013 | |
Last Trade Price | Rs 133.28 | |
3 Months Avg | Rs 118.95 | |
6 Months Avg | Rs 122.02 | |
9 Months Avg | Rs 107.31 | |
12 Months Avg | Rs 98.89 | |
Score | -16 | cumulative +ve's, -ve's from above all |
Buy Scale | -1 | Range -5 to +5 (based on 5 different complex analysis) |
No comments:
Post a Comment